| |
TRI group |
TFI group |
| Success rate of PCI [n (%)] |
308(90.58) |
294(91.58) |
In-hospital
MACCE [n (%)]
Myocardial infarction[n (%)]
Death [n (%)]
LVEF(%)
At one-month follow up
MACCE [n (%)]
Myocardial infarction[n (%)]
Death [n (%)]
LVEF (%) |
10(2.94)
3(0.88)
4(1.17)
53.2±11.4
13(3.82)
5(1.47)
5(1.47)
54.5±10.6 |
21(6.54)*
7(2.18)
12(3.73) *
52.6±13.7
24(7.47)*
10(3.11)
12(3.73) *
53.2±16.5 |
| Hospitalization time(days) |
5.4±2.6 |
7.1±3.7** |
| Major bleeding[n (%)] |
4(1.17) |
10(3.11) |
Vascular access site
complications [n (%)] |
6(1.76) |
18(5.6) ** |
| Hematoma[n (%)] |
4(1.17) |
12(3.73) * |
| Pseudoaneurysm[n (%)] |
1(0.29) |
3(0.93) |
Artery-venous fistula[n (%)]
Radial occlusion[n (%)] |
1(0.29)
14(4.11) |
3(0.93)
1(0.31) ** |
Values are presented as mean ± standard deviation or n (%).
*Denotes statistical difference (p < 0.05) compared to normal group; **Denotes
statistical difference (p < 0.01) compared to normal group.
TRI,transradial intervention;TFI,transfemoral intervention;PCI,percutaneous coronary
intervention;MACCE,major adverse cardiovascular and cerebrovascular
events; LVEF, left ventricular ejection fraction. |
